The stimulatory effect of the octadecaneuropeptide (ODN) on cytosolic Ca2+ in rat astrocytes is not mediated through classical benzodiazepine receptors

European Journal of Pharmacology

Volumn 322, Issue 2-3, 1997, Pages 275-281

  Gandolfo, Pierrick ^a   Patte, Christine ^a   Leprince, Jérôme ^a   Thoumas, Jean Louis ^a   Vaudry, Hubert ^a   Tonon, Marie Christine ^a  

^a UNIVERSITÉ DE ROUEN   (France)

Author keywords

Benzodiazepine receptor; Ca2+ mobilization; Diazepam binding inhibitor; Endozepine; Glial cell; Octadecaneuropeptide (ODN)

Indexed keywords

4' CHLORODIAZEPAM; BENZODIAZEPINE RECEPTOR; BENZODIAZEPINE RECEPTOR BLOCKING AGENT; BENZODIAZEPINE RECEPTOR STIMULATING AGENT; CLONAZEPAM; DIAZEPAM BINDING INHIBITOR; FLUMAZENIL; FLUNITRAZEPAM; N SEC BUTYL 1 (2 CHLOROPHENYL) N METHYL 3 ISOQUINOLINECARBOXAMIDE; OCTADECANEUROPEPTIDE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BINDING SITE; CALCIUM CELL LEVEL; CALCIUM MOBILIZATION; DRUG RECEPTOR BINDING; GLIA CELL; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR AFFINITY;

ANIMALS; ASTROCYTES; CYTOSOL; DIAZEPAM BINDING INHIBITOR; FLUOROMETRY; LIGANDS; NEUROPEPTIDES; PEPTIDE FRAGMENTS; PROTEIN BINDING; RATS; RATS, WISTAR; RECEPTORS, GABA-A;

EID: 0030900923     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(97)00012-5     Document Type: Article

References (47)

1. Alho, H., R.T. Fremeau, H. Tiedge, J. Wilcox, P. Bovolin, J. Brosius, J.L. Roberts and E. Costa, 1988, Diazepam-binding inhibitor gene expression: location in brain and peripheral tissues of the rat, Proc. Natl. Acad. Sci. USA 85, 7018.
2. Alho, H., V. Varga and K.E. Krueger, 1994, Expression of mitochondrial benzodiazepine receptor and its putative endogenous ligand diazepam-binding inhibitor in cultured primary astrocytes and C-6 cells: relation to cell growth, Cell Growth Differ. 5, 1005.
3. Anholt, R.R.H., P.L. Pederson, E.B. De Souza and S.H. Snyder, 1986, The peripheral-type benzodiazepine receptor: localization to the mitochondrial outer membrane, J. Biol. Chem. 261, 576.
4. 3H]PK 11195, an isoquinoline carboxamide derivative: kinetic studies and autoradiographic localization, J. Neurochem. 41, 1744.
5. - channels in cultured astrocytes, Proc. Natl. Acad. Sci. USA 85, 9336.
6. Bovolin, P., J. Schlichting, M. Miyata, C. Ferrarese, A. Guidotti and H. Alho, 1990, Distribution and characterization of diazepam-binding inhibitor (DBI) in peripheral tissues of rat, Regul. Pept. 29, 267.
7. A receptor proteins in mature brain, J. Neurochem. 65, 2006.
8. Chen, Z.W., B. Agerberth, K. Gell, M. Andersson, V. Mutt, C.G. Ostenson, S. Efendic, J. Barros-Soderling, B. Persson and H. Jornvall, 1988, Isolation and characterization of porcine diazepam-binding inhibitor, a polypeptide not only of cerebral occurrence but also common in intestinal tissues and with effects on regulation of insulin release, Eur. J. Biochem. 174, 239.
9. Costa, E., J. Auta, A. Guidotti, A. Korneyev and E. Romeo, 1994, The pharmacology of neurosteroidogenesis, J. Steroid Biochem. Mol. Biol. 49, 385.
10. De Souza, E.B., R.R.H. Anholt, K.M.M. Murphy, S.H. Snyder and M.J. Kuhar, 1985, Peripheral-type benzodiazepine receptors in endocrine organs: autoradiographic localization in rat pituitary, adrenal and testis, Endocrinology 116, 567.
11. Ferrero, P., M.R. Santi, B. Conti-Tronconi, E. Costa and A. Guidotti, 1986, Study of an octadecaneuropeptide derived from diazepam-binding inhibitor (DBI): biological activity and presence in rat brain, Proc. Natl. Acad. Sci. USA 83, 827.
12. Garnier, M., N. Boujrad, B.O. Oke, S. Brown, J. Riond, P. Ferrera, M. Shoyab, C.A. Suarez-Quian and V. Papadopoulos, 1993, Diazepambinding inhibitor is a paracrine/autocrine regulator of Leydig cell proliferation and steroidogenesis: action via peripheral-type benzodiazepine receptor and independent mechanisms, Endocrinology 132, 444.
13. Gavish, M., Y. Katz, S. Bar-Ami and R. Weizman, 1992, Biochemical, physiological, and pathological aspects of the peripheral benzodiazepine receptor, J. Neurochem. 58, 1589.
14. 2+ mobilization in amphibian pituitary cells, Endocrinology 131, 1.
15. Guarneri, P., V. Papadopoulos, B. Pan and E. Costa, 1992, Regulation of pregnenolone synthesis in C6-2B glioma cells by 4′-chlorodiazepam, Proc. Natl. Acad. Sci. USA 89, 5118.
16. Guidotti, A., C.M. Forchetti, M.G. Corda, D. Kondel, C.D. Bennett and E. Costa, 1983, Isolation, characterization and purification to homogeneity of an endogenous polypeptide with agonistic action on benzodiazepine receptors, Proc. Natl. Acad. Sci. USA 80, 3531.
17. Itzhak, Y., L. Baker and M.D. Norenberg, 1993, Characterization of the peripheral-type benzodiazepine receptors in cultured astrocytes: evidence for multiplicity, Glia 9, 211.
18. Johansson, O., M. Hilliges, C.G. Ostenson, E. Sandberg, S. Efendic and V. Mutt, 1991, Immunohistochemical localization of porcine diazepam-binding inhibitor (DBI) to rat endocrine pancreas, Cell Tissue Res. 263, 395.
19. A receptors comprising the α3, β1 and γ2 subunits, Eur. J. Neurosci. 4, 1.
20. Knudsen, J., P. Hojrup, H.O. Hansen, H.F. Hansen and P. Roepstorff, 1989, Acyl-CoA-binding protein in the rat. Purification, binding characteristics, tissue concentrations and aminoacid sequence, Biochem. J. 262, 513.
21. 2+ in cultured astrocytes, Mol. Brain Res. 37, 290.
22. 2+ concentrations in frog adrenocortical cells in primary culture, Endocrinology 131, 1087.
23. Lesouhaitier, O., M. Feuilloley, I. Lihrmann, I. Ugo, A. Fasolo, M.C. Tonon and H. Vaudry, 1996, Localization of diazepam-binding inhibitor-related peptides and peripheral-type benzodiazepine receptors in the frog adrenal gland, Cell Tissue Res. 283, 403.
24. Lihrmann, I., J.C. Plaquevent, H. Tostivint, R. Raijmakers, M.C. Tonon, J.M. Conlon and H. Vaudry, 1994, Frog diazepam-binding inhibitor: peptide sequence, cDNA cloning and expression in the brain, Proc. Natl. Acad. Sci. USA 91, 6899.
25. Lin, D., Y.J. Chang, J.F. Strauss III and W.L. Miller, 1993, The human peripheral benzodiazepine receptor gene: cloning and characterization of alterning splicing in normal tissues and in a patient with congenital lipoid adrenal hyperplasia, Genomics 18, 43.
26. Malagon, M., H. Vaudry, F. Van Strien, G. Pelletier, F. Gracia-Navarro and M.C. Tonon, 1993, Ontogeny of diazepam-binding inhibitor-related peptides (endozepines) in the rat brain, Neuroscience 57, 777.
27. Marquardt, H., G.J. Todaro and M. Shoyab, 1986, Complete amino acid sequences of bovine and human endozepines. Homology with rat diazepam binding inhibitor, J. Biol. Chem. 261, 9727.
28. McEnery, M.W., A.M. Snowman, R.R. Trifiletti and S. Snyder, 1992, Isolation of the mitochondrial benzodiazepine receptor: association with the voltage-dependent anion channel and the adenine nucleotide carrier, Proc. Natl. Acad. Sci. USA 89, 3170.
29. Moynagh, P.N., A. Schousboe and D.C. Williams, 1994, The peripheral-type benzodiazepine receptor is present in astrocytes but is not a primary site of action for convulsants/anticonvulsants, J. Neurochem. 62, 673.
30. Oke, B.O., C.A. Suarez-Quian, J. Riond, P. Ferrara and V. Papadopoulos, 1992, Cell surface localization of the peripheral-type benzodiazepine receptor (PBR) in adrenal cortex, Mol. Cell. Endocrinol. 87, R1.
31. Ostenson, C.G., B. Ahren, S. Karlsson, J. Knudsen and S. Efendic, 1994, Inhibition by rat diazepam-binding inhibitor/acyl-CoA-binding protein of glucose-induced insulin secretion in the rat, Eur. J. Endocrinol. 131, 201.
32. Papadopoulos, V., A. Berkovich, K.E. Krueger, E. Costa and A. Guidotti, 1991. Diazepam-binding inhibitor and its processing products stimulate mitochondrial steroid biosynthesis via an interaction with mitochondrial benzodiazepine receptors, Endocrinology 129, 1481.
33. Papadopoulos, V., P. Guarneri, K.E. Krueger, A. Guidotti and E. Costa, 1992. Pregnenolone biosynthesis in C6-2B glioma cell mitochondria: regulation by a mitochondrial diazepam binding inhibitor receptor, Proc. Natl. Acad. Sci. USA 89, 5113.
34. Patte, C., H. Vaudry, L. Desrues, P. Gandolfo, I. Strijdveen, M. Lamacz and M.C. Tonon, 1995, The endozepine ODN stimulates polyphosphoinositide metabolism in rat astrocytes, FEBS Lett. 362, 106.
35. Puia, G., M.R. Santi, S. Vicini, D.B. Pritchett, P.H. Seeburg and E. Costa, 1989, Differences in the negative allosteric modulation of γ-aminobutyric acid receptors elicited by 4′-chlorodiazepam and by a β-carboline-3-carboxylate ester: a study with natural and reconstituted receptors, Proc. Natl. Acad. Sci. USA 86, 7275.
36. Rhéaume, E., M.C. Tonon, F. Smih-Rouet, J. Simard, L. Désy, H. Vaudry and G. Pelletier, 1990, Localization of the endogenous benzodiazepine ligand octadecaneuropeptide (ODN) in the rat testis, Endocrinology 127, 1986.
37. Rose, T.M., E.R. Schultz, G.C. Sasaki, P.E. Kolattukudy and M. Shoyab, 1994, Nucleotide sequence and genomic structure of duck acyl-CoA binding protein/diazepam-binding inhibitor: co-localization with S-acyl fatty acid synthase thioesterase, DNA Cell Biol. 13, 669.
38. A receptor channel expressed in Xenopus oocytes, J. Neurosci. 8, 289.
39. Slobodyansky, E., A. Guidotti, C. Wambebe, A. Berkovich and E. Costa, 1989, Isolation and characterization of a triakontatetraneuropeptide (TTN) a posttranslational product of diazepam-binding inhibitor: specific action at the Ro5-4864 recognition sites, J. Neurochem. 53, 1276.
40. Steyaert, H., M.C. Tonon, F. Smih-Rouet, J. Testart, G. Pelletier and H. Vaudry, 1991, Distribution and characterization of endogenous benzodiazepine receptor ligand (endozepine)-like peptides in the rat gastrointestinal tract, Endocrinology 129, 2101.
41. Taupin, V., A. Herbelin, B. Descamps-Latscha and F. Zavala, 1991, Endogenous anxiogenic peptide, ODN-diazepam-binding inhibitor, and benzodiazepines enhance the production of interleukin-1 and tumor necrosis factor by human monocytes, Lymphokine Cytokine Res. 10, 7.
42. Tong, Y., D. Toranzo and G. Pelletier, 1991, Localization of diazepam-binding inhibitor (DBI) mRNA in the rat brain by high resolution in situ hybridization, Neuropeptides 20, 33.
43. Tonon, M.C., S. Adjeroud, M. Lamacz, E. Louiset, J.M. Danger, L. Desrues, L. Cazin, P. Nicolas and H. Vaudry, 1989, Central-type benzodiazepines and the octadecaneuropeptide (ODN) modulate the effects of γ-aminobutyric acid on the release of α-melanocyte stimulating hormone from frog neurointermediate lobe in vitro, Neuroscience 31, 485.
44. Tonon, M.C., L. Désy, P. Nicolas, H. Vaudry and G. Pelletier, 1990, Immunocytochemical localization of the endogenous benzodiazepine ligand octadecaneuropeptide (ODN) in the rat brain, Neuropeptides 15, 17.
45. A /benzodiazepine receptor, Neurosci. Lett. 115, 131.
46. Vidnyanszky, Z., T.J. Gores and J. Hamori, 1994, Diazepam-binding inhibitor fragment 33-50 (octadecaneuropeptide) immunoreactivity in the cerebellar cortex is restricted to glial cells, Glia 10, 132.
47. 1 cells stimulated by arachidonic acid, Int. J. Immunopharmacol. 9, 269.